A single test for rejecting the null hypothesis in subgroups and in the overall sample

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Medical Research

Background:

• Clinical trials often observe varying treatment effect sizes across different patient subgroups.
• Conventional statistical methods may not fully leverage subgroup-specific effect size information.
• Identifying subgroups with potentially larger treatment benefits is crucial for personalized medicine.

Purpose of the Study:

• To propose a novel test statistic that incorporates pre-specified subgroup ordering of effect sizes.
• To enhance statistical power in clinical trials when effect sizes differ across subgroups.
• To simultaneously test hypotheses at both the subgroup and overall sample levels.

Main Methods:

• Developed a test statistic that combines p-values from subgroup and overall sample analyses.
• Assigned differential weighting to subgroups based on expected effect size magnitude.
• Applied the method to randomized trials with two and three pre-specified subgroups.

Main Results:

• The proposed method demonstrated increased statistical power compared to conventional tests when effect size differences across subgroups were substantial.
• The test effectively integrates subgroup information into the overall hypothesis testing framework.
• Performance was evaluated in scenarios with varying degrees of effect size heterogeneity.

Conclusions:

• The novel weighted p-value combination method offers a more powerful approach for analyzing clinical trial data with expected subgroup differences in treatment effects.
• This technique can improve the detection of treatment benefits in specific patient populations.
• The method provides a valuable supplement to standard statistical analyses in clinical research.